ExploreOutcomePlasma lipid measurement
Outcome

Plasma lipid measurement

Also known as: Plasma lipid levels (HDL-C, triglycerides, LDL-C) Plasma lipid measurement Plasma lipid measurement (procedure) Plasma lipids Plasma lipids (procedure)
3 findings 1 paper 3 related entities View in graph →

Related entities

interventions
conditions
studys

Findings (27)

None
improvement

Fenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group

Effect: improvement; HDL-C +6.3%, triglycerides -21.2%

Size: HDL-C +6.3%, triglycerides -21.2%
None
improvement

Fenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group

Effect: improvement; HDL-C +6.3%, triglycerides -21.2%

Size: HDL-C +6.3%, triglycerides -21.2%
None
improvement

Fenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group

Effect: improvement; HDL-C +6.3%, triglycerides -21.2%

Size: HDL-C +6.3%, triglycerides -21.2%
None
improvement

Fenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group

Effect: improvement; HDL-C +6.3%, triglycerides -21.2%

Size: HDL-C +6.3%, triglycerides -21.2%
None
improvement

Fenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group

Effect: improvement; HDL-C +6.3%, triglycerides -21.2%

Size: HDL-C +6.3%, triglycerides -21.2%
None
improvement

Fenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group

Effect: improvement; HDL-C +6.3%, triglycerides -21.2%

Size: HDL-C +6.3%, triglycerides -21.2%
None
improvement

Fenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group

Effect: improvement; HDL-C +6.3%, triglycerides -21.2%

Size: HDL-C +6.3%, triglycerides -21.2%
None
improvement

Fenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group

Effect: improvement; HDL-C +6.3%, triglycerides -21.2%

Size: HDL-C +6.3%, triglycerides -21.2%
None
improvement

Fenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group

Effect: improvement; HDL-C +6.3%, triglycerides -21.2%

Size: HDL-C +6.3%, triglycerides -21.2%
None
improvement

Fenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group

Effect: improvement; HDL-C +6.3%, triglycerides -21.2%

Size: HDL-C +6.3%, triglycerides -21.2%
None
improvement

Fenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group

Effect: improvement; HDL-C +6.3%, triglycerides -21.2%

Size: HDL-C +6.3%, triglycerides -21.2%
None
improvement

Fenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group

Effect: improvement; HDL-C +6.3%, triglycerides -21.2%

Size: HDL-C +6.3%, triglycerides -21.2%
None
improvement

Fenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group

Effect: improvement; HDL-C +6.3%, triglycerides -21.2%

Size: HDL-C +6.3%, triglycerides -21.2%
None
improvement

Fenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group

Effect: improvement; HDL-C +6.3%, triglycerides -21.2%

Size: HDL-C +6.3%, triglycerides -21.2%
None
improvement

Fenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group

Effect: improvement; HDL-C +6.3%, triglycerides -21.2%

Size: HDL-C +6.3%, triglycerides -21.2%
None
improvement

Fenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group

Effect: improvement; HDL-C +6.3%, triglycerides -21.2%

Size: HDL-C +6.3%, triglycerides -21.2%
None
improvement

Fenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group

Effect: improvement; HDL-C +6.3%, triglycerides -21.2%

Size: HDL-C +6.3%, triglycerides -21.2%
None
improvement

Fenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group

Effect: improvement; HDL-C +6.3%, triglycerides -21.2%

Size: HDL-C +6.3%, triglycerides -21.2%
None
improvement

Fenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group

Effect: improvement; HDL-C +6.3%, triglycerides -21.2%

Size: HDL-C +6.3%, triglycerides -21.2%
None
improvement

Fenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group

Effect: improvement; HDL-C +6.3%, triglycerides -21.2%

Size: HDL-C +6.3%, triglycerides -21.2%
None
improvement

Fenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group

Effect: improvement; HDL-C +6.3%, triglycerides -21.2%

Size: HDL-C +6.3%, triglycerides -21.2%
None
improvement

Fenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group

Effect: improvement; HDL-C +6.3%, triglycerides -21.2%

Size: HDL-C +6.3%, triglycerides -21.2%
None
improvement

Fenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group

Effect: improvement; HDL-C +6.3%, triglycerides -21.2%

Size: HDL-C +6.3%, triglycerides -21.2%
None
improvement

Fenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group

Effect: improvement; HDL-C +6.3%, triglycerides -21.2%

Size: HDL-C +6.3%, triglycerides -21.2%
None
improvement

Fenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group

Effect: improvement; HDL-C +6.3%, triglycerides -21.2%

Size: HDL-C +6.3%, triglycerides -21.2%
None
improvement

Fenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group

Effect: improvement; HDL-C +6.3%, triglycerides -21.2%

Size: HDL-C +6.3%, triglycerides -21.2%
None
improvement

Fenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group

Effect: improvement; HDL-C +6.3%, triglycerides -21.2%

Size: HDL-C +6.3%, triglycerides -21.2%

Papers (1)